Amedisys, Inc. (NASDAQ:AMED) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On December14, 2016, the Board of Directors of Amedisys, Inc.
(the Company) appointed Gary Willis as the Companys Chief
Financial Officer, effective as of January3, 2017. Mr.Willis, 51,
previously served as the Executive Vice President and Chief
Financial Officer of Capella Healthcare, a healthcare services
company, from September 2015 through the date of its merger with
RegionalCare Hospital Partners in May 2016. Prior to Capella,
Mr.Willis served as the Chief Financial Officer of Martin
Ventures, a healthcare venture capital firm, from March 2014
through September 2015. Prior to Martin Ventures, Mr.Willis
served as the Senior Vice President and Chief Accounting Officer
of Vanguard Health Systems, a healthcare services company, from
2008 through March 2014.
Mr.Willis will participate in the Amedisys Holding, L.L.C.
Severance Plan for Key Executives dated April30, 2015, as
amended. Mr.Willis does not have a family relationship with any
of the current officers or directors of the Company. There is no
currently proposed transaction, and since the beginning of fiscal
year 2015 there has not been any transaction, involving the
Company and Mr.Willis which was a related person transaction
within the meaning of Item404(a) of Regulation S-K.
Ronald A. LaBorde, the Vice Chairman and Chief Financial Officer
of the Company, will continue to serve as the Companys Chief
Financial Officer through January2, 2017 and will serve as Vice
Chairman until April2, 2017.
On December16, 2016, the Company and Daniel P. McCoy, the
Companys Chief Operating Officer, mutually agreed that Mr.McCoy
will be leaving the Company effective as of January3, 2017 in
connection with the previously announced appointment of
Christopher Gerard as the Companys Chief Operating Officer.
Mr.McCoys departure from the Company will constitute a
resignation with good reason.
| Item7.01. | Regulation FD Disclosure. |
On December20, 2016, the Company issued a press release
announcing the appointment of Mr.Willis as the Companys Chief
Financial Officer, effective January3, 2017, a copy of which is
furnished herewith as Exhibit 99.1 to this Current Report on
Form8-K.
The information included in this Current Report on Form 8-K under
this Item7.01 (including Exhibit 99.1 hereto) is being furnished
and shall not be deemed to be filed for the purposes of Section18
of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise subject to the liabilities of Section18, nor
shall it be incorporated by reference into a filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such
filing. The information included in this Current Report on Form
8-K under this Item7.01 (including Exhibit 99.1 hereto) will not
be deemed an admission as to the materiality of any information
required to be disclosed solely to satisfy the requirements of
Regulation FD.
| Item9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
|
Exhibit Number |
Description |
|
| 99.1 | Press Release dated December 20, 2016 |
About Amedisys, Inc. (NASDAQ:AMED)
Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company’s home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company’s personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico. Amedisys, Inc. (NASDAQ:AMED) Recent Trading Information
Amedisys, Inc. (NASDAQ:AMED) closed its last trading session up +0.35 at 43.20 with 322,129 shares trading hands.
